Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.
Ozempic Maker’s Stock Plunges 20% After Profit Warning
Subscribe
0 Comments
Oldest